文献速递病毒性肝炎

血浆纤连蛋白水平预测慢性乙型肝炎HBsAg清除

Plasma Fibronectin Levels Identified via Quantitative Proteomics Profiling Predicts Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
PubMed 文献 · J Infect Dis · 2019-01-01

本研究通过定量蛋白质组学分析慢性乙型肝炎患者血浆蛋白,发现纤连蛋白与HBsAg自发清除相关。对于年HBsAg log下降>0.5的患者,清除前1年纤连蛋白预测HBsAg清除的AUC为0.884。

要点

  • 血浆纤连蛋白水平与慢性乙肝HBsAg自发清除相关。
  • HBsAg清除前1年纤连蛋白对清除有预测价值,AUC达0.884。
  • 纤连蛋白可能作为功能性治愈的潜在预测标志物。

核心结论

  • 血浆纤连蛋白可能与HBsAg清除相关,是功能性治愈的潜在预测指标。

研究设计与样本

  • 前瞻性招募未治疗慢性乙肝患者,包括自发HBsAg清除者和匹配的HBsAg阳性对照。
  • 使用基于iTRAQ的蛋白质组学进行血浆蛋白谱分析,并在独立队列中验证候选蛋白。
  • 在清除前3年、1年及清除时评估纤连蛋白的预测价值。

主要发现

  • 年HBsAg log下降>0.5的患者中,清除前1年纤连蛋白预测HBsAg清除的AUC为0.884。

临床怎么用

  • 纤连蛋白或可作为预测慢性乙肝患者HBsAg清除的辅助生物标志物。
  • 对年HBsAg log下降>0.5的患者,可考虑检测纤连蛋白以评估功能性治愈可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Seroclearance of hepatitis B surface antigen (HBsAg) is a potentially achievable target of chronic hepatitis B (CHB). Plasma proteins relevant to HBsAg seroclearance remain undetermined. METHODS: We prospectively recruited treatment-naive CHB patients with spontaneous HBsAg seroclearance and matched HBsAg-positive controls. Plasma protein profiling was performed using isobaric tags for relative and absolute quantitation-based proteomics, with the expression of candidate proteins validated in a separate cohort. The predictive value of fibronectin was assessed at 3 years, 1 year (Year -1) before, and at the time (Year 0) of HBsAg seroclearance. RESULTS: Four hundred eighty-seven plasma proteins were identified via proteomics, with 97 proteins showing altered expression. In the verification cohort (n = 90), median plasma fibronectin levels in patients with HBsAg seroclearance was higher than in controls (P = .009). In the longitudinal cohort (n = 164), patients with HBsAg seroclearance, compared with controls, had a higher median fibronectin levels at Year -1 (413.26 vs 227.95 µg/mL) and Year 0 (349.45 vs 208.72 µg/mL) (both P < .001). In patients with an annual HBsAg log reduction >0.5, Year -1 fibronectin level achieved an area under the receiving operator characteristic of 0.884 in predicting HBsAg seroclearance. CONCLUSIONS: Using proteomics-based technology, plasma fibronectin may be associated with HBsAg seroclearance and a potential predictor of "functional cure".

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Liu F, Seto WK, Wong DK, et al. Plasma Fibronectin Levels Identified via Quantitative Proteomics Profiling Predicts Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B. J Infect Dis. 2019. PMID: 31056649. doi:10.1093/infdis/jiz223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。